Published: Sat, September 23, 2017
Money | By Armando Alvarado

Johnson & Johnson (NYSE:JNJ) Institutional Investor Sentiment Trend

Johnson & Johnson (NYSE:JNJ) Institutional Investor Sentiment Trend

The stock declined 1.35% or $1.83 reaching $133.39 on the news. Johnson & Johnson had 65 analyst reports since August 7, 2015 according to SRatingsIntel. Following the completion of the transaction, the vice president now directly owns 226,693 shares in the company, valued at $30,993,466.96. Finally, BidaskClub downgraded shares of Johnson & Johnson from a "strong-buy" rating to a "buy" rating in a research note on Saturday, July 1st. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. This translates into $4.80 billion profit for JNJ giving the stock a 18.55 P/E. As per Tuesday, October 13, the company rating was maintained by TH Capital. Ruby Tuesday, Inc. (RT) has $128.59M valuation. Moreover, Brandes Inv Prns LP has 0.26% invested in Johnson & Johnson (NYSE:JNJ). They expect $0.06 EPS, down 71.43% or $0.15 from last year's $0.21 per share. Roth Capital maintained it with "Buy" rating and $1200 target in Thursday, July 27 report. Wellcome Tru Limited (The) As Trustee Of The Wellcome Tru has 1.70 million shares for 3.83% of their portfolio. Crossvault Capital Management LLC now owns 41,146 shares of the company's stock valued at $5,443,000 after purchasing an additional 475 shares during the period. The firm has "Neutral" rating given on Wednesday, April 20 by Goldman Sachs. IPAS's SI was 79,300 shares in September as released by FINRA. During the same quarter past year, the firm posted $1.74 earnings per share. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: and their article: "Pfizer sues Johnson & Johnson, alleging anticompetitive practices to maintain ..." published on September 20, 2017 as well as's news article titled: "China's WuXi, Johnson & Johnson-backed XW Labs lands $17.5M series B" with publication date: September 20, 2017.

The company has mean EPS estimate of 1.73 reported by 19 number of analyst for the quarter ending Current Qtr.(Sep2017). The hedge fund held 772,513 shares of the technology company at the end of 2017Q2, valued at $24.18M, up from 755,774 at the end of the previous reported quarter. UBS AG reiterated a "buy" rating and issued a $148.00 price objective on shares of Johnson & Johnson in a research report on Thursday, August 31st. The firm has "Hold" rating by Jefferies given on Friday, July 14. It dived, as 50 investors sold JNJ shares while 878 reduced holdings. If the published price targets set by Johnson & Johnson analysts have any power to influence the stock's share price, the highest price target set for JNJ is $150.

Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. FBR Capital upgraded the shares of HPT in report on Friday, November 11 to "Outperform" rating. Also, VP Paulus Stoffels sold 102,692 shares of the company's stock in a transaction on Monday, July 24th. It last reported revenues of $4.09 billion and EPS of $0.46 for the June 2017, representing -7% top-line growth and 0.63 EPS growth.

Caldwell & Orkin Inc increased Zillow Group Inc. Whole Foods Mkt Inc (Put) (NASDAQ:WFM) was raised too. Osterweis stated it has 210,470 shares or 2.12% of all its holdings. Hoertkorn Richard Charles has invested 1.05% in Johnson & Johnson (NYSE:JNJ).

Investors sentiment decreased to 1.58 in 2017 Q2. Wealth Enhancement Advisory reported 0.16% in Johnson & Johnson (NYSE:JNJ). Gluskin Sheff Assocs Inc holds 0.02% or 1,345 shares. 30,300 are owned by Crestpoint Management Ltd Liability Corp. BTIG Research downgraded the stock to "Sell" rating in Friday, July 21 report. Its down 0.85, from 2.43 in 2017Q1. As per Friday, September 25, the company rating was maintained by Macquarie Research. 22 funds opened positions while 47 raised stakes. Kessler Gru Limited Co reported 4.39% stake.

Latest update on power outages in Central Florida
Hurricane Irma hit South Florida Sunday September 10 and the nursing home lost some power around 3 p.m. One transformer handles life and safety systems while the second supports the air conditioning system.

Blue Fin Capital Inc, which manages about $165.51 million and $155.43 million US Long portfolio, upped its stake in Ishares Msci Emerging Markets Etf (EEM) by 7,620 shares to 114,474 shares, valued at $4.74 million in 2017Q2, according to the filing. Poplar Forest Capital Lc invested in 0.19% or 16,657 shares. Shares for $6,100 were bought by Griffiths Gary A on Wednesday, May 10. Federated Invsts Inc Pa has 0% invested in Ruby Tuesday, Inc. Lbmc Investment Advisors LLC lifted its position in Johnson & Johnson by 0.4% in the first quarter. The data from the past twelve months tells a similar story: insiders executed 10 buys and 25 sells, and ownership decreased by a net of 411959 shares. Westpac Corporation has invested 0% of its portfolio in Praxair, Inc. (NASDAQ:IPAS). Howe & Rusling Incorporated holds 0% or 5,000 shares. Bridgeway Cap Management stated it has 1.07% of its portfolio in Johnson & Johnson (NYSE:JNJ). Heritage Wealth holds 15,711 shares or 1.08% of its portfolio.

Looking forward, the company's quarterly earnings are expected to come at $0.46 in the three months through September 2017 and $0.51 in the quarter ending December 2017, reflecting -17.86% and -5.56% growth, respectively.

In the most updated research from a number of analysts on Wall Street, the company gets 9 Buys and 2 Sell among 21 analysts. Therefore 45% are positive. The stock presently has a consensus rating of Hold and an average price target of $135.29. The firm has "Buy" rating given on Wednesday, May 24 by Aegis Capital.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this: